Pre-Open Stock Movers: Athenex (NASDAQ:ATNX) 61% HIGHER; reports from the Economic Times that Intas and Dr. Reddy’s Labs (NYSE:RDY) are in talks to acquire the company for...
After-Hours Stock Movers: Athenex (NASDAQ:ATNX) 61% HIGHER; reports from the Economic Times that Intas and Dr. Reddys Labs (RDY) are in talks to acquire the company for $200-$250...
Biotechnology stocks represent companies that research, develop or market healthcare-related therapies or products. They typically use living organisms, biological systems, or...
Recent positive news about a COVID-19 vaccine has put the limelight on health-care and pharmaceutical companies, especially BioNTtech (NASDAQ:BNTX), Moderna (NASDAQ:MRNA) and...
Dr. Reddy's Laboratories Ltd. (NYSE:RDY) reported third-quarter fiscal 2020 loss of 48 cents per share, per American Depositary Share (ADS). However, the loss includes an...
Dr. Reddy's Laboratories Limited is an India-based pharmaceutical company. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
|Average||64.80 (+29.86% Upside)|
|No. of Analysts||3|